Robert F. Kennedy Jr.'s supporters are eager to rein in direct-to-consumer pharmaceutical ads, claiming they mislead Americans about important health topics. But this anti-pharma coalition faces an awkward dilemma. After pushing regulatory rollbacks at FDA last year, they're now hindered by the very limitations on agency authority they demanded. Do we need to ban pharma ads, and is there a viable way to do it?